NICE gives nod to rivaroxaban as treatment for pulmonary embolism

04/19/2013 | Fox Business

The U.K.'s National Institute for Health and Care Excellence has endorsed the use of anti-clotting drug rivaroxaban in patients with pulmonary embolism. The decision gives doctors an alternative to combined heparin and warfarin to reduce the risk of a repeat embolism.

View Full Article in:

Fox Business

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Chief Financial Officer
Health Alliance Plan of Michigan
Southfield, MI
Senior Vice-President Managed Care Mid-Atlantic Region
Mercy Health System
Conshohocken, PA
Associate Chief Financial Officer
Commonwealth Care Alliance
Boston, MA
Assistant General Counsel, Regulatorya
Cardinal Health
Waukegan, IL
Chief Operating Officer
Health Plan of San Joaquin
French Camp , CA